Why Did Bill Ackman Buy Alphabet Stock?
Bill Ackman has become famous in the investing world for…
Sell
49
CNVVY Quote, Financials, Valuation and Earnings
Last price:
$13.99
Seasonality move
:
4.22%
Day range:
$13.62 - $13.99
52-week range:
$10.77 - $14.50
Dividend yield:
1.85%
P/E ratio:
37.61x
P/S ratio:
3.14x
P/B ratio:
4.23x
Volume:
3.6K
Avg. volume:
8.5K
1-year change:
2.87%
Market cap:
$7.2B
Revenue:
$2.3B
EPS (TTM):
$0.37
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, ConvaTec Group PLC has -- downside to fair value with a price target of -- per share.
CNVVY vs. S&P 500
-
Over the past 5 trading days, ConvaTec Group PLC has overperformed the S&P 500 by 1.5% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
ConvaTec Group PLC does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
ConvaTec Group PLC has grown year-over-year revenues for 0 quarters straight. In the most recent quarter ConvaTec Group PLC reported revenues of --.
Earnings Growth
-
ConvaTec Group PLC has grown year-over-year earnings for 0 quarters straight. In the most recent quarter ConvaTec Group PLC reported earnings per share of --.
Enterprise value:
8.2B
EV / Invested capital:
--
Price / LTM sales:
3.14x
EV / EBIT:
25.70x
EV / Revenue:
3.59x
PEG ratio (5yr expected):
0.19x
EV / Free cash flow:
29.95x
Price / Operating cash flow:
26.24x
Enterprise value / EBITDA:
15.19x
Gross Profit (TTM):
$1.3B
Return On Assets:
5.27%
Net Income Margin (TTM):
8.32%
Return On Equity:
11.35%
Return On Invested Capital:
6.56%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2017-06-30 | 2018-06-30 | 2019-06-30 | 2018-06-30 | 2019-06-30 | |
| Income Statement | ||||||
| Revenue | $1.7B | $1.9B | $1.8B | -- | -- | |
| Gross Profit | $897.9M | $977.7M | $952.6M | -- | -- | |
| Operating Income | $188.1M | $277M | $239.3M | -- | -- | |
| EBITDA | $280.1M | $454.7M | $438.1M | -- | -- | |
| Diluted EPS | -$0.23 | $0.48 | $0.32 | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.2B | $1.1B | $889.3M | $870M | $793.3M | |
| Total Assets | $3.8B | $3.7B | $3.6B | $3.7B | $3.5B | |
| Current Liabilities | $513.2M | $569.2M | $533.1M | $536.4M | $512.3M | |
| Total Liabilities | $2.1B | $2B | $2B | $2B | $1.8B | |
| Total Equity | $1.7B | $1.7B | $1.6B | $1.7B | $1.7B | |
| Total Debt | $1.5B | $1.3B | $1.2B | $1.2B | $1.1B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2013-03-31 | 2014-03-31 | 2015-03-31 | 2014-03-31 | 2015-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | $10B | $10.9B | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | $11.6B | $13.7B | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
CNVVY
Sector
Market Cap
$7.2B
$35M
Price % of 52-Week High
96.48%
44.47%
Dividend Yield
1.85%
0%
Shareholder Yield
--
-0.9%
1-Year Price Total Return
2.87%
-38.53%
Beta (5-Year)
0.945
0.738
Dividend yield:
1.85%
Annualized payout:
$0.25
Payout ratio:
68.35%
Growth streak:
2 years
Technicals
8-day SMA
Buy
Level
$13.78
200-day SMA
Buy
Level
$12.33
Bollinger Bands (100)
Buy
Level
11.57 - 13.53
Chaikin Money Flow
Buy
Level
79K
20-day SMA
Buy
Level
$13.46
Relative Strength Index (RSI14)
Buy
Level
54.59
ADX Line
Buy
Level
13.17
Williams %R
Sell
Level
-16.2698
50-day SMA
Buy
Level
$13.34
MACD (12, 26)
Buy
Level
1.77
25-day Aroon Oscillator
Buy
Level
44
On Balance Volume
Sell
Level
-22.1K
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.6382)
Buy
CA Score
(Annual)
Level (0.0339)
Buy
Beneish M-Score
(Annual)
Level (-2.7499)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-0.551)
Buy
Piotroski F Score
(Annual)
Level (8)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Originally spun out of Bristol-Myers Squibb, ConvaTec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and ostomy supplies are the largest divisions, accounting for 33% and 28% of total revenue, respectively. Continence care has become a slightly smaller business (21% of revenue) following the decision to exit the acute care market, and infusion sets contribute 18% of consolidated revenue.
Stock Forecast FAQ
In the current month, CNVVY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CNVVY average analyst price target in the past 3 months is --.
-
Where Will ConvaTec Group PLC Stock Be In 1 Year?
According to analysts, the consensus estimate is that ConvaTec Group PLC share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About ConvaTec Group PLC?
Analysts are divided on their view about ConvaTec Group PLC share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that ConvaTec Group PLC is a Sell and believe this share price will rise from its current level to --.
-
What Is ConvaTec Group PLC's Price Target?
The price target for ConvaTec Group PLC over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is CNVVY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for ConvaTec Group PLC is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of CNVVY?
You can purchase shares of ConvaTec Group PLC via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase ConvaTec Group PLC shares.
-
What Is The ConvaTec Group PLC Share Price Today?
ConvaTec Group PLC was last trading at $13.99 per share. This represents the most recent stock quote for ConvaTec Group PLC. Yesterday, ConvaTec Group PLC closed at $13.99 per share.
-
How To Buy ConvaTec Group PLC Stock Online?
In order to purchase ConvaTec Group PLC stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Bill Ackman Buy Brookfield Stock?
Bill Ackman of Pershing Square Capital has made a number…
Why Is Chewy Stock Up — And Will It Keep Climbing?
We are all witnesses to the crazy e-commerce industry boom…
Stock Ideas
Buy
61
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 34x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
59
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Sell
27
SAIA alert for Apr 26
Saia [SAIA] is down 30.77% over the past day.
Sell
48
APPF alert for Apr 26
AppFolio [APPF] is down 18.16% over the past day.
Sell
15
KNSL alert for Apr 26
Kinsale Capital Group [KNSL] is down 16.33% over the past day.
